Researchers explore the role of of transposable elements in myocarditis

May 23, 2024 12:59 AM AEST | By EIN Presswire
 Researchers explore the role of of transposable elements in myocarditis
Image source: EIN Presswire

USA, May 22, 2024 /EINPresswire.com/ -- This study explores the role of transposable elements (TEs) in modulating immune responses in cardiomyopathy, using RNA-Seq and single-cell sequencing data from a mouse model of experimental autoimmune myocarditis. Findings reveal significant upregulation of immune genes and specific expression of ERVB7-1.LTR-MM transposon across various immune cells, suggesting TEs' substantial impact on the disease's immune mechanisms.

Regarded historically as genomic parasites, transposable elements (TEs) have now been recognized as significant contributors to cellular identity and function, especially in immune regulation.

Mammalian genomes contain a vast number of TEs The diversity and abundance of these elements impact the structure, function and evolution of the genome. They influence gene regulatory networks by altering transcription factor binding sites and creating new enhancer activities. Increasingly, there is evidence that underscores the crucial role of TEs in various diseases, especially in modulating immunity. However, in the context of myocarditis, there has been a notable lack of focus on the impact of TEs, highlighting a potential research area that could provide new insights into the molecular mechanisms driving this cardiac disease.

In a study (https://doi.org/10.1016/j.repbre.2024.03.001) published in the KeAi journal Reproduction and Breeding, a team of researchers from Hunan Normal University utilized RNA-Seq and single-cell RNA-Seq data to identify key TEs associated with myocarditis.

The team used publicly available databases to explore the role of TEs in myocarditis.RNA Seq data and single-cell sequencing data were analyzed, with a focus on the mouse model of experimental autoimmune myocarditis (EAM). The RNA-Seq analysis revealed substantial upregulation of a range of immune genes in cardiac tissue.

“We furthered the investigation using single-cell sequencing of cardiac immune cells identified specific expression of certain transposable elements (TEs) across different types of immune cells in the heart,” shares first author of the study, Sixing Chen. “We observed an overall increase in the expression of the ERVB7-1.”

LTR-MM transposon across various cells in the EAM model suggest a widespread impact of this transposon on the immune response in this disease context.

“Our findings highlight the intricate interaction between TEs and the immune system in cardiomyopathy, providing new insights into the molecular mechanisms underlying this condition,” adds Chen.

In particularly, the discovery of specific TEs expression in cardiac immune cells and the overall increase in ERVB7-1. LTR-MM expression across the EAM model underscore the potential of these elements in modulating immune responses and contribute to our understanding of cardiomyopathy's pathogenesis. These observations open avenues for further research into the role of TEs in cardiac diseases, optimizing novel therapeutic strategies.

DOI
10.1016/j.repbre.2024.03.001

Original Source URL
https://doi.org/10.1016/j.repbre.2024.03.001

Funding information
The present study was funded by National Natural Science Foundation of China (Nos: 31872315, 81970324, 81700338, 81800289, 81670290);the Hunan Provincial Natural Science Foundation of China (No. 2023JJ30396) and Key Projects of Hunan Provincial Department of Education (No.23A0082).

Lucy Wang
BioDesign Research
email us here


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.